# Valproic Acid for Idiopathic Nephrotic Syndrome

> **NCT02896270** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 15 (estimated)

## Conditions studied

- Idiopathic Nephrotic Syndrome
- Focal Segmental Glomerulosclerosis
- Minimal Change Disease

## Interventions

- **DRUG:** Valproic Acid

## Key facts

- **NCT ID:** NCT02896270
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-10
- **Final completion:** 2019-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02896270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02896270, "Valproic Acid for Idiopathic Nephrotic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02896270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*